Biomarkers for the early stages of Alzheimer's
(the best possible design)
Please Help Support Alzheimer's Research Today!
Please Help Support Alzheimer's Research Today!
Your Alzheimer's donation will help billions live without it.
With Alzheimer's disease increasing in prevalence and public awareness, more people are becoming interested in learning their chances of developing this condition. Disclosing Alzheimer's disease risk has been discouraged because of the limited predictive value of available tests, lack of prevention and treatment options, and concerns regarding potential psychological and social harms. However, challenges to this status quo include the availability of direct-to-consumer health risk information (e.g., genetic susceptibility tests), as well as a growing literature suggesting that people seeking risk information for Alzheimer's disease through formal education and counseling protocols generally find it useful and do not experience adverse effects. This paper reviews current and potential methods of risk assessment for Alzheimer's disease, discusses the process and impact of disclosing risk to interested patients and consumers, and considers the practical and ethical challenges in this emerging area. Anticipated future directions are addressed. Read more: ncbi.nlm.nih.gov
Probiotics against common cold
Daily supplements with probiotic Lactobacillus strains may reduce the incidence of acquiring the common cold by 12 percent, according to new research from probiotic player Probi. Read more: nutraingredients.com
No comments:
Post a Comment